0042 Proteomic Biomarkers Of Circadian Time

[摘要] IntroductionOur ability to incorporate circadian timing into clinical decision-making is impaired by our inability to measure circadian phase efficiently. This impacts treatment for patients with suspected circadian rhythm disorders and insomnia or hypersomnia. The current Dim Light Melatonin Onset (DLMO) method for assessing circadian time is expensive and necessitates multiple samples over several hours. We utilized an aptamer approach to quantify circadian time.

[学科分类] 生理学